Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 4/20 | 0.68 |
| ▸ | GABRD | O14764 | 4/20 | 0.68 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.68 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.68 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.68 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.68 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.68 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.68 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.68 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.68 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.68 |
| ▸ | GABRE | P78334 | 4/20 | 0.68 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.68 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.68 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.68 |
| ▸ | GABRQ | Q9UN88 | 4/20 | 0.68 |
| ▸ | KDM1A | O60341 | 2/20 | 0.68 |
| ▸ | CCNC | P24863 | 2/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.68 |
| ▸ | CDK8 | P49336 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norwogonin SCHEMBL30485998 | 1.00 | GABRP (0.68) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL8511222 | 0.88 | ABCB1 (0.61) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL476215 | 0.88 | CBS (0.78) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL28986431 | 0.88 | CBS (0.78) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29435853 | 0.88 | CBS (0.78) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6614337 | 0.85 | KDM4E (0.62) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31051320 | 0.85 | KDM4E (0.62) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29149073 | 0.85 | GABRP (0.70) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL28066043 | 0.85 | GABRP (0.65) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4783697 | 0.84 | ALDH1A1 (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | claimed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| EP-0859557-A4 | FOODS AND BEVERAGES CONTAINING ANTHOCYANINS STABILIZED BY PLANT EXTRACTS | HAUSER INC (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| US-5908650-A | INTENSITY; STABILITY; MIXTURE CONTAINING FLAVONOIDS | HAUSER, INC. (US) | 1999-06-01 | — | — | US | claimed |
| EP-0859557-A1 | FOODS AND BEVERAGES CONTAINING ANTHOCYANINS STABILIZED BY PLANT EXTRACTS | Hauser Inc. (US) | 1998-08-26 | — | — | EP | claimed |
| WO-1997014319-A1 | FOODS AND BEVERAGES CONTAINING ANTHOCYANINS STABILIZED BY PLANT EXTRACTS | HAUSER CHEMICAL RESEARCH, INC. (US) | 1997-04-24 | — | — | WO | claimed |
| CN-1033365-C | Composition based on hydrate lamellar lipides or liposomes, containing extract of scutellaria, or at least component thereof, and cosmeties or pharmaceutical, especially having anti-allergic,......... | LVMH RECH (FR) | 1996-11-27 | — | — | CN | claimed |
| EP-0332478-B1 | LIPOSOMES CONTAINING SCUTELLARIA EXTRACTS | LVMH RECH (FR) | 1992-03-25 | — | — | EP | claimed |
| CN-1037834-A | With hydration lamellar fat mutually or liposome is the compositions of main component, wherein contain the Radix Scutellariae extract or contain wherein a kind of component at least, and cosmetics or medicament, especially skin is had antiallergic, the compositions of antiinflammatory or defying age performance | LVMH RECH (FR) | 1989-12-13 | — | — | CN | claimed |
| WO-1989008447-A1 | LIPOSOMES CONTAINING SCUTELLARIA EXTRACTS | LVMH RECHERCHE (FR) | 1989-09-21 | — | — | WO | claimed |
| EP-0332478-A1 | Liposomes containing Scutellaria extracts | LVMH RECHERCHE (FR) | 1989-09-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | GABRP 145/4885GABRD 778/4885GABRA1 568/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | GABRP 1001/4885GABRD 3081/4885GABRA1 2063/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | GABRP 1001/4885GABRD 3081/4885GABRA1 2063/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | GABRP 2625/4885GABRD 4203/4885GABRA1 3922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.